Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Aerie Pharmaceuticals
Work at Aerie Pharmaceuticals?
Add yourself to this profile
2932
Aerie Pharmaceuticals
Aerie Pharmaceuticals is focused on developing products for the pharmaceuticaltreatment of glaucoma.
Edit Profile
aeriepharma.com
Technology
>
Biotechnology
Health Care
>
Medical
>
Pharmaceuticals
B2c
Founded in
2005
Raised
$331.4M
More info
Elsewhere
Contributors to this profile
Companies in the same industry
Alimera Sciences
KannaLife Sciences
DoIt4YourDaughters
SutroVax
Prometheon Pharma
Eiger BioPharmaceuticals, Inc.
AFFiRiS AG
Oculis
Adynxx
NemaMetrix, Inc.
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
Undisclosed
$40,000,000
Novartis Venture Fund
,
OrbiMed
,
Kearny Venture Partners
, +3
Post-IPO equity
$125,000,000
Employees
Team size
10+
Locations
HQ
United States
Headquarters
$40,000,000
Undisclosed
PE Hub
Aerio Pharmaceuticals takes in about $40 mln
Funding
Messaging
$125,000,000
Post-IPO equity
businesswire
Aerie Pharmaceuticals Raises $125 Million in Public Offerings | Business Wire
The Motley Fool
Why Safety Data Is Sending Aerie Pharmaceuticals Soaring Today
Stock markets
Alimera Sciences
KannaLife Sciences
DoIt4YourDaughters
SutroVax
Prometheon Pharma
NemaMetrix, Inc.